Information about Gans Investors
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0865.470.523

VAT liability
Yes
Established
13-05-2004
Last balance sheet year
2025
Company size
Small 0 FTE
Commercial name
Apotheek Rooseleers
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Gans Investors

2025 2024 2023 2022
Profit/Loss 144,351 4,09% 138,678 40,2% 98,917 35,08% 73,230
Equity 917,055 18,68% 772,704 20,92% 639,027 18,31% 540,109
Gross margin 102,587 9,41% 93,768 23,62% 75,852 45,31% 52,200

Publications from Gans Investors

Date Publication
27-07-2023 Capital - Shares - Resignations - Appointments (NL)
08-01-2018 Designation - Registered Office - Goal - Capital - Shares (NL)
21-03-2014 Capital - Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
08-06-2004 Constitution (NL)

Frequently asked questions

What is the VAT number of Gans Investors?
The VAT number of Gans Investors is BE 0865.470.523.
Wat is the PEPPOL ID of Gans Investors?
The PEPPOL ID of Gans Investors is 0208:0865470523. Log in or start a free trial to see the full overview.
When was Gans Investors founded?
Gans Investors was founded on 13-05-2004.
What is the address of Gans Investors?
The current registered office of Gans Investors is located at Mollenveldwijk 22A, 3271 Scherpenheuvel-Zichem.
When was the last time Gans Investors filed their annual financial statements?
The most recent financial statements of Gans Investors were filed on 23-07-2026.
How many employees does Gans Investors have?
There are currently no employees working at Gans Investors or no workforce information is available.
What is the annual turnover of Gans Investors?
At the time of its most recent financial statements, Gans Investors did not publish any turnover figures. Gans Investors reported a gross margin of €102,586.92.